Race influences the safety and efficacy of spironolactone in severe heart failure.
Vardeny O, Cavallari LH, Claggett B, Desai AS, Anand I, Rossignol P, Zannad F, Pitt B, Solomon SD; Randomized Aldactone Evaluation Study (RALES) Investigators.
Vardeny O, et al.
Circ Heart Fail. 2013 Sep 1;6(5):970-6. doi: 10.1161/CIRCHEARTFAILURE.113.000530. Epub 2013 Aug 12.
Circ Heart Fail. 2013.
PMID: 23940307
Free article.
Clinical Trial.